CN102441033A - Chinese medicine magnolia flower powder for treating chronic rhinitis - Google Patents
Chinese medicine magnolia flower powder for treating chronic rhinitis Download PDFInfo
- Publication number
- CN102441033A CN102441033A CN2010105024165A CN201010502416A CN102441033A CN 102441033 A CN102441033 A CN 102441033A CN 2010105024165 A CN2010105024165 A CN 2010105024165A CN 201010502416 A CN201010502416 A CN 201010502416A CN 102441033 A CN102441033 A CN 102441033A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- chronic rhinitis
- parts
- magnolia flower
- flower powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses Chinese medicine magnolia flower powder for treating chronic rhinitis. The Chinese medicine magnolia flower powder comprises the following traditional Chinese medicine components in part by weight: 19-21 parts of magnolia flower, 9-11 parts of chrysanthemum and 9-11 parts of ligusticum wallichii. The components of the Chinese medicine magnolia flower powder are common pure traditional Chinese medicine; and the Chinese medicine magnolia flower powder has the characteristics of reasonable compounding, no toxic or side effect and better oral taking effect in the aspect of use.
Description
Technical field
The invention belongs to the Chinese medicine technical field of pharmaceuticals, especially a kind of Chinese medicine Magnoliae Powder of treating chronic rhinitis.
Background technology
Chronic rhinitis is the nonspecific inflammation of bronchia mucosal and Submucosa more than the lasting several months, or inflammation shows effect repeatedly, and Submucosa also can not recover normal person in the phase of gap.Clinical in persistence or intermittence, property nasal obstruction alternately, nasal mucus increases and is characteristic.Primary disease is many thoroughly not to be developed, develops and cause because of the acute rhinitis treatment.Be divided into chronic simple rhinitis and chronic hypertrophic rhinitis clinically.Its clinical manifestation is:
Chronic simple rhinitis: nasal obstruction is intermittent or property alternately, generally by day, movable back nasal obstruction alleviates or disappear; Night, sat quietly for a long time, tired, meet that nasal obstruction increases the weight of when cold.When lying on one's side, the upside nasal airflow is good, the downside congestion.Mostly nasal mucus is mucus.The congested swelling of nasal mucosa is seen in inspection, is main with concha nasalis inferior, smooth surface, that touches is flexible, caves in the mucosa that can make of probe pressures, remove probe after recess can calm down very soon.Responsive to vasoconstrictor response.
Hypertrophic rhinitis: having a stuffy nose is persistence, and rhinophonia is heavier, and hyposmia is obvious, and the nasal mucus amount is few and glutinous, is difficult for blowing out.The visible bronchia mucosal of inspection is kermesinus or pale asphyxia, and the concha nasalis hypertrophy is loose, and performance is uneven, and is nodal-like or Fructus Mori appearance, and the poor flexibility of touching with the depression that is difficult for of probe pressures, removes that depression is difficult behind the probe calms down very soon.Insensitive to vasoconstrictor response.The Therapeutic Principle of primary disease recovers the nasal airflow function for eradicating the cause of disease, removes secretions.
The traditional Chinese medical science claims that primary disease is " stuffy nose ", is mostly evil stagnant, the caused by energy stagnation and blood stasis of the deficiency of the lung.Chronic rhinitis has intractable and recurrent characteristics, and common Western medicine is all cured the symptoms, not the disease, and is difficult to it is thoroughly eradicated.
Therefore, the Chinese medicine Magnoliae Powder that needs a kind of new treatment chronic rhinitis is with better treatment chronic rhinitis.
Summary of the invention
In view of this, the present invention is devoted to better to treat chronic rhinitis, has proposed a kind of Chinese medicine Magnoliae Powder of treating chronic rhinitis.
According to technical scheme of the present invention, a kind of Chinese medicine Magnoliae Powder of treating chronic rhinitis is provided.This Chinese medicine Magnoliae Powder comprises the Chinese medicinal components that following weight ratio is formed: Flos Magnoliae 19-20 part, Flos Chrysanthemi 9-10 part, Rhizoma Chuanxiong 9-10 part.
Its best main being divided into: 20 parts of Flos Magnoliaes, 10 parts of Flos Chrysanthemis, 10 parts of Rhizoma Chuanxiongs.
Use usage: the Chinese medicine of said components ratio is ground into smalls.Day obeys 2 times, each 6g, and children's is cut down according to the circumstance.Sooner or later respectively once.10 days is a course of treatment, and take effect a course of treatment, and can eradicate 3 courses of treatment.Food, Semen phaseoli radiati, green tea etc. avoid pungent food during the medication.
Among the present invention, Flos Magnoliae: dispel the wind, sensible.Control headache, nasal sinusitis, it is obstructed to have a stuffy nose, toothache.
Flos Chrysanthemi: the wind heat clearing away of loosing, suppressing the hyperactive liver make eye bright.
Rhizoma Chuanxiong: blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping.
The present invention treats the Chinese medicine Magnoliae Powder expelling wind and cold of chronic rhinitis, and reducing swelling and alleviating pain improves the internal medium of nose and repairs the nasal membrane tissue that pathological changes takes place.Be applicable to common rhinitis etc., life-time service has the elimination effect to the intractable chronic rhinitis.
Through the result that clinical 200 examples are used, cure rate reaches 93.7%, and (recovery from illness: nasal airflow is good, and secretions reduces; The nasal conchae hypertrophy situation is thoroughly improved; The headache situation that occurs together disappears), the improver reaches 4% (improver: more preceding ventilation has improvement and secretions to reduce, but does not see normal fully).
Clinical practice instance of the present invention is following:
Instance one, Zhang Gang, the man, 35 years old, black rich people from Shizhong District suffered from surplus the chronic rhinitis 10 year, long-term nasal obstruction, watery nasal discharge, the concha nasalis enlargement, intermittent headache occurs together.Use Chinese medicine Magnoliae Powder of the present invention for oral administration, take effect 1 course of treatment, and thoroughly eradicate 3 courses of treatment, and concha nasalis recovers original size, and not recurrence in 3 years.
Instance two, Lin Li, the woman, 44 years old, Accessories during Binzhou people suffered from chronic rhinitis 7 years, during cold and hot season alternation, sneeze often, the situation aggravation does not have olfactory sensation fully when getting angry, and the nose ventilation is not smooth.Use Chinese medicine Magnoliae Powder of the present invention, for oral administration 1 the course of treatment sx, removed symptom 2 courses of treatment, under the doctor advises, takes the 3rd course of treatment, rhinitis is not recommitted so far.
Instance three, Zhang Huankang, the man, 4 years old, people from Jining City, caught a cold from 2 years old chronic rhinitis, when outbreak, adopt intranasal to splash into vasoconstrictor usually, can improve the ventilation and the drain of nasal cavity like 1% ephedrine etc., inflammation is disappeared, but but outbreak often.Use Chinese medicine Magnoliae Powder of the present invention, 1 course of treatment for oral administration, nasal discharge obviously reduces, and inspection sees that the congested situation of nasal mucosa is eased, use 3 courses of treatment after, symptom is thoroughly eliminated, and does not have recurrence so far.
Instance four, Wang Haijun, the man, 45 years old, the office worker of Jinan statistics bureau suffered from chronic rhinitis 5 years.Because intranasal hamartoplasia, mucomembranous surface is uneven, and concha nasalis inferior is the Fructus Mori shape to be changed, and the middle nasal concha mucosa is polypoid and becomes, hypopnea, olfactory sensation completely without.Take 1 course of treatment of Chinese medicine Magnoliae Powder of the present invention, breath state is eased, and after 2 courses of treatment, olfactory sensation part gradually recovers, and it is smooth that nasal mucosa begins to become, and after 3 courses of treatment, olfactory sensation recovers, and concha nasalis inferior restores to the original state, and the middle nasal concha polyp disappears.
Instance five, Xue Liping, the woman, 31 years old, the Chengbei District people of Qingdao City suffered from chronic rhinitis 10 years.Forehead pain is lain awake all night unbearably when serious, and it is obstructed to have a stuffy nose, and intracavity has the pus point, and purulent secretion is arranged, and once accepts puncture for treating, and effect is not ideal enough, often recurrence.After take 1 course of treatment of Chinese medicine Magnoliae Powder of the present invention, nasal cavity purulence thing reduces, ventilation makes moderate progress.Again through the treatments of 2 courses of treatment, the rhinitis transference cure, its headache that occurs together does not occur yet, not recurrence in 2 years.
The invention has the beneficial effects as follows: the present invention adopts Chinese medicine preparation, and side effect is little, simultaneously, only can thoroughly be eradicated through taking medicine of certain course of treatment the intractable chronic rhinitis, and expense is relatively also low.
The specific embodiment
In order better to treat chronic rhinitis, the invention provides a kind of Chinese medicine Magnoliae Powder of treating chronic rhinitis.
Next combine embodiment to specify the Chinese medicine Magnoliae Powder of this treatment chronic rhinitis.
Embodiment one
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 19 parts of Flos Magnoliaes, 9 parts of Flos Chrysanthemis, 9 parts of Rhizoma Chuanxiongs.The Chinese medicine of said components ratio is ground into smalls.
Embodiment two
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 20 parts of Flos Magnoliaes, 10 parts of Flos Chrysanthemis, 10 parts of Rhizoma Chuanxiongs.The Chinese medicine of said components ratio is ground into smalls.
Embodiment three
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 21 parts of Flos Magnoliaes, 11 parts of Flos Chrysanthemis, 11 parts of Rhizoma Chuanxiongs.The Chinese medicine of said components ratio is ground into smalls.
Embodiment four
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 20 parts of Flos Magnoliaes, 11 parts of Flos Chrysanthemis, 11 parts of Rhizoma Chuanxiongs.The Chinese medicine of said components ratio is ground into smalls.
More than be the implementation that specific descriptions of the present invention are intended to explain specific embodiments, can not be interpreted as it is limitation of the present invention.Those of ordinary skills can make various variants on the basis of the embodiment that details under instruction of the present invention, these variants all should be included within the design of the present invention.The present invention's scope required for protection is only limited by described claims.
Claims (2)
1. a Chinese medicine Magnoliae Powder of treating chronic rhinitis is characterized in that: comprise the Chinese medicinal components that following weight ratio is formed: Flos Magnoliae 19-20 part, Flos Chrysanthemi 9-10 part, Rhizoma Chuanxiong 9-10 part.
2. the Chinese medicine Magnoliae Powder of treatment chronic rhinitis as claimed in claim 1 is characterized in that: comprise the Chinese medicinal components that following weight ratio is formed: 20 parts of Flos Magnoliaes, 10 parts of Flos Chrysanthemis, 10 parts of Rhizoma Chuanxiongs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105024165A CN102441033A (en) | 2010-10-11 | 2010-10-11 | Chinese medicine magnolia flower powder for treating chronic rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105024165A CN102441033A (en) | 2010-10-11 | 2010-10-11 | Chinese medicine magnolia flower powder for treating chronic rhinitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102441033A true CN102441033A (en) | 2012-05-09 |
Family
ID=46004293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105024165A Pending CN102441033A (en) | 2010-10-11 | 2010-10-11 | Chinese medicine magnolia flower powder for treating chronic rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441033A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327085A (en) * | 2015-12-09 | 2016-02-17 | 钟柱林 | Pharmaceutical composition for treating children chronic simple rhinitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1552363A (en) * | 2003-05-29 | 2004-12-08 | 毛友昌 | Pungent rhinitis pills and their preparation |
| CN1883624A (en) * | 2006-05-26 | 2006-12-27 | 张静 | Medicine for treating chronic rhinitis and nasal sinusitis and method for preparing same |
-
2010
- 2010-10-11 CN CN2010105024165A patent/CN102441033A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1552363A (en) * | 2003-05-29 | 2004-12-08 | 毛友昌 | Pungent rhinitis pills and their preparation |
| CN1883624A (en) * | 2006-05-26 | 2006-12-27 | 张静 | Medicine for treating chronic rhinitis and nasal sinusitis and method for preparing same |
Non-Patent Citations (6)
| Title |
|---|
| 叶强: "《常见病自疗——常见病食疗便方》", 31 August 2001, 广州出版社 * |
| 李凡成: "鼻科炎症的证治体会", 《江苏中医杂志》 * |
| 段振离: "祛风通窍说辛夷", 《中国中医药报》 * |
| 肖国豪: "逍遥散加味治疗32例鼻窦炎", 《新中医》 * |
| 郝芬兰: "川芎茶调散加味袋泡剂治疗慢性鼻窦炎126例", 《四川中医》 * |
| 马芳等: "苍菊通窍汤治疗慢性鼻炎、鼻窦炎60例疗效观察", 《河北中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327085A (en) * | 2015-12-09 | 2016-02-17 | 钟柱林 | Pharmaceutical composition for treating children chronic simple rhinitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102793747A (en) | Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis | |
| CN101987190A (en) | Traditional Chinese medicine for efficiently treating rhinitis | |
| CN103463416A (en) | Traditional Chinese medicine preparation for treating rhinitis and pharyngitis | |
| CN101979022A (en) | Chinese medicinal mixture for treating chronic rhinitis | |
| CN103356792A (en) | Chinese medicine composition for treating chronic rhinitis | |
| CN102895313B (en) | Traditional Chinese medicine composition for treating diseases of ophthalmology and otorhinolaryngology | |
| CN102451238B (en) | Chinese medicinal preparation for treating rhinitis | |
| CN102772650B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN102441033A (en) | Chinese medicine magnolia flower powder for treating chronic rhinitis | |
| CN103893266A (en) | Traditional Chinese medicine used for treating nasal obstruction | |
| CN103285169A (en) | Traditional Chinese medicine pill for treatment of chronic rhinitis | |
| CN104706789A (en) | Traditional Chinese medicine for treating chronic suppurative otitis media | |
| CN101670050B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN102793735A (en) | Chinese medicinal angelica dahurica powder for treating chronic rhinitis | |
| CN101804182B (en) | Traditional Chinese medicine prescription for treating nasal sinusitis | |
| CN102697894B (en) | Medicinal composition for treating nasal cavity inflammatory disease and preparation method thereof | |
| CN103110749B (en) | Traditional Chinese medicine composition for treating chloasma | |
| CN103505525A (en) | Medicament for treating haemorrhoids and preparation method thereof | |
| CN101757255B (en) | Traditional Chinese medicine for treating chronic rhinitis | |
| CN104189083A (en) | Chinese herbal preparation for treating acute maxillary sinusitis | |
| CN104547046A (en) | Traditional Chinese medicinal composition for treating nasosinusitis | |
| CN104161854A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN103520564A (en) | Traditional Chinese medicine composition for treating bronchiectasia | |
| CN109876066A (en) | A kind of Traditional Chinese medicine liniment and preparation method thereof for treating nasopharyngeal carcinoma | |
| CN102784252A (en) | Chinese medicine composition for treating nasosinusitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120509 |